Teva Pharmaceutical Industries Limited Stock Forecast
Teva Pharmaceutical Industries Limited stock price ended at $13.25 on Thursday, after gaining 1.84%.
(Updated on Apr 25, 2024)
The Teva Pharmaceutical Industries Limited stock price gained 1.84% on the last trading day (Thursday, 25th Apr 2024), rising from $13.01 to $13.25. During the last trading day the stock fluctuated 3.91% from a day low at $12.80 to a day high of $13.30. The price has risen in 5 of the last 10 days but is still down by -4.47% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 1 million more shares were traded than the day before. In total, 8 million shares were bought and sold for approximately $112.18 million.
The stock lies in the lower part of a wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $12.89 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 10.35% during the next 3 months and, with a 90% probability hold a price between $14.23 and $16.42 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
TEVA Signals & Forecast
There are mixed signals in the stock today. The Teva Pharmaceutical Industries Limited stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $13.60. On a fall, the stock will find some support from the short-term average at $13.00. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Wednesday, March 27, 2024, and so far it has fallen -8.18%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.
Support, Risk & Stop-loss for Teva Pharmaceutical Industries Limited stock
Teva Pharmaceutical Industries Limited finds support from accumulated volume at $12.91 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.500 between high and low, or 3.91%. For the last week, the stock has had daily average volatility of 2.78%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (TEVA) For The Upcoming Trading Day Of Friday 26th
For the upcoming trading day on Friday, 26th we expect Teva Pharmaceutical Industries Limited to open at $13.12, and during the day (based on 14 day Average True Range), to move between $12.89 and $13.61, which gives a possible trading interval of +/-$0.361 (+/-2.73%) up or down from last closing price. If Teva Pharmaceutical Industries Limited takes out the full calculated possible swing range there will be an estimated 5.45% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $13.29 (0.30%) than the support at $12.91 (2.57%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Teva Pharmaceutical Industries Limited stock A Buy?
Teva Pharmaceutical Industries Limited holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.
Current score: -2.295 Sell Candidate Unchanged
Predicted Opening Price for Teva Pharmaceutical Industries Limited of Friday, April 26, 2024
| Fair opening price April 26, 2024 | Current price |
|---|---|
| $13.12 ( 1.01%) | $13.25 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for TEVA
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 13.62 | 2.77 % | |
| R2 | 13.43 | 1.33 % | ||
| R1 | 13.31 | 0.435 % | ||
| Current price: | 13.25 | |||
| Support | S1 | 12.93 | -2.45 % | |
| S2 | 12.81 | -3.34 % | ||
| S3 | 12.62 | -4.78 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 13.50 | 1.89 % | |
| R2 | 13.30 | 0.377 % | ||
| R1 | 13.29 | 0.302 % | ||
| Current price | 13.25 | |||
| Support | S1 | 12.91 | -2.57% | |
| S2 | 12.10 | -8.68% | ||
| S3 | 11.73 | -11.47% |
TEVA Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | Nov 02, 2017 | Nov 27, 2017 | Dec 12, 2017 | $0.0850 | 0.515% |
| 2 | Aug 07, 2017 | Aug 25, 2017 | Sep 14, 2017 | $0.0850 | 0.463% |
| 3 | May 11, 2017 | Jun 01, 2017 | Jun 22, 2017 | $0.340 | 1.05% |
| 4 | Feb 13, 2017 | Feb 28, 2017 | Mar 20, 2017 | $0.340 | 1.01% |
| 5 | Nov 15, 2016 | Dec 01, 2016 | Dec 20, 2016 | $0.340 | 0.94% |
FAQ
Click here for our free guide on how to buy Teva Pharmaceutical Industries Limited Stock.
